[CLDX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
04-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -6.16%
YoY- -34.37%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 3,647 3,113 2,009 2,433 2,434 2,363 1,952 51.40%
PBT -16,807 -15,027 -13,362 -13,083 -12,294 -11,334 -9,802 43.02%
Tax -94 -105 -252 -410 268 -288 -158 -29.15%
NP -16,807 -15,027 -13,773 -13,516 -12,732 -11,772 -10,236 38.96%
Tax Rate - - - - - - - -
Total Cost 20,454 18,140 15,782 15,949 15,166 14,135 12,188 40.99%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -460.84 -482.72 -685.56 -555.53 -523.09 -498.18 -524.39 -8.21%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -4.03 -3.79 -3.52 -4.04 -3.81 -4.00 -4.10 -1.13%
EPS Diluted -4.03 -3.79 -3.52 -4.04 -3.81 -4.00 -4.10 -1.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.